SWM
RDY icon

Selective Wealth Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Selective Wealth Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,500
Closed -$18K – 541
2021
Q1 		$18K Hold
1,500
– – 0.02% 204
2020
Q4 		$21K Hold
1,500
– – 0.01% 182
2020
Q3 		$21K Hold
1,500
– – 0.02% 155
2020
Q2 		$16K Buy
+1,500
New +$15.3K 0.01% 198

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Selective Wealth Management's RDY Position: Q2 2021 in Review

Selective Wealth Management sold out of Dr. Reddy's Laboratories (RDY) in Q2 2021, closing a stake of 1,500 shares — an estimated $18K sold.

Selective Wealth Management first reported a position in RDY in Q2 2020 and held it in 4 quarters. The position peaked at $21K in Q4 2020. 161 funds tracked by Wall St. Rank hold RDY as of Q2 2021.

  • Selective Wealth Management reported no remaining Dr. Reddy's Laboratories position as of Q2 2021 after selling out during the quarter.
  • Selective Wealth Management sold 1,500 Dr. Reddy's Laboratories shares in Q2 2021, an estimated $18K.
  • Selective Wealth Management first reported a position in Dr. Reddy's Laboratories in Q2 2020 and held it in 4 quarters.
  • Selective Wealth Management's Dr. Reddy's Laboratories position peaked at $21K in Q4 2020.
  • 161 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2021.

Based on Selective Wealth Management's 13F filing for Q2 2021, filed 8 Jul 2021.